616450 Sigma-AldrichTGF-β1, Human Platelets
Recommended Products
Overview
| Replacement Information |
|---|
Key Spec Table
| Purity |
|---|
| ≥97% by SDS-PAGE |
| Product Information | |
|---|---|
| Form | Lyophilized |
| Formulation | Lyophilized from a sterile-filtered solution of 50 µg BSA/µg TGF-β1, 35% acetonitrile, 0.1% TFA. |
| Quality Level | MQ100 |
| Applications |
|---|
| Physicochemical Information | |
|---|---|
| Contaminants | Endotoxin: ≤1 EU/ug of TGF-β1 |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| 616450 | 0 |
Documentation
Required Licenses
| Title |
|---|
| PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD |
TGF-β1, Human Platelets SDS
| Title |
|---|
TGF-β1, Human Platelets Certificates of Analysis
| Title | Lot Number |
|---|---|
| 616450 |
References
| Reference overview |
|---|
| Lomo, J., et al. 1995. J. Immunol. 154, 1634. Marushige, K. and Marushige, Y. 1995. Anticancer Res. 14, 2419. Bermundez, L.E. 1993. J. Immunol. 150, 1838. Hamilton, J.A., et al. 1993. J. Immunol. 150, 1496. Reilly, J.T., et al. 1993. Br. J. Haematol. 83, 58. Sporn, M.B. and Roberts, A.B. 1993. Growth Factors 8, 1. |



